$SNEX

Perkins Abigail H sold $292K of SNEX

Perkins Abigail H (Chief Information Officer) sold 4,500 shares of StoneX Group Inc. (SNEX) at $64.81 ($0.29M total) on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Perkins Abigail H
Published Aug 11, 2026, 11:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 12:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
medium confidence
Mentioned
$SNEX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The newest disclosed fact is the specific open-market sale size, price, and post-transaction holdings for the CIO, executed under a pre-arranged 10b5-1 plan.

02

Market read

This is a routine insider sale disclosure with limited incremental information for trading beyond confirming insider liquidity activity.

03

What to watch

The article does not state whether other insiders sold/bought around the same window, nor does it provide context on option exercises, tax-related sales, or plan size versus typical activity.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-11 after-hours; sale executed 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for StoneX Group Inc.

Company-level read

Ticker impact

$SNEXNeutralMedium confidence
Context

StoneX Group CIO Perkins Abigail H sold 4,500 shares on 2026-08-10 at $64.8138, totaling $291,662.10 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale.

Evidence & confidence

The filing is a scheduled 10b5-1 open-market sale by an officer, with no accompanying operational, financial, or regulatory catalyst disclosed.

Market effects

Minimal, as this is company-specific insider trading with no sector-wide regulatory or earnings signal.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with private concerns about near-term fundamentals, so traders may watch for follow-on disclosures.

Key entities

  • StoneX Group Inc.

    Subject of the Form 4 insider transaction disclosure (SNEX).

  • Perkins Abigail H

    Chief Information Officer who executed the 10b5-1 open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.